Review Article | Open Access
Gandikota Girish, David M. Melville, Gurjit S. Kaeley, Catherine J. Brandon, Janak R. Goyal, Jon A. Jacobson, David A. Jamadar, "Imaging Appearances in Gout", Arthritis, vol. 2013, Article ID 673401, 10 pages, 2013. https://doi.org/10.1155/2013/673401
Imaging Appearances in Gout
Gout is an ancient disease. Last decade has brought about significant advancement in imaging technology and real scientific growth in the understanding of the pathophysiology of gout, leading to the availability of multiple effective noninvasive diagnostic imaging options for gout and treatment options fighting inflammation and controlling urate levels. Despite this, gout is still being sub-optimally treated, often by nonspecialists. Increased awareness of optimal treatment options and an increasing role of ultrasound and dual energy computed tomography (DECT) in the diagnosis and management of gout are expected to transform the management of gout and limit its morbidity. DECT gives an accurate assessment of the distribution of the deposited monosodium urate (MSU) crystals in gout and quantifies them. The presence of a combination of the ultrasound findings of an effusion, tophus, erosion and the double contour sign in conjunction with clinical presentation may be able to obviate the need for intervention and joint aspiration in a certain case population for the diagnosis of gout. The purpose of this paper is to review imaging appearances of gout and its clinical applications.
Gout is the most common cause of inflammatory arthritis in men  and its prevalence is rapidly expanding in the general population . It is associated with an excess of uric acid in the body. This results in supersaturation of uric acid in body tissues and fluids resulting in urate deposition. Over 80% of the gout patients have a positive family history of gout or hyperuricemia. The disease is best understood as having four phases which include asymptomatic hyperuricemia, acute, intercritical, and chronic gout. The musculoskeletal manifestations of gout are triggered by the deposition of monosodium urate (MSU) crystals in cartilage, joints, and soft tissues. Acute gout attacks are due to the triggering of an inflammation pathway known as the NALP3 inflammasome by MSU crystals in the joint  and soft tissues. The diagnosis of gout is confirmed by the presence of intracellular MSU crystals in a joint aspirate . MSU crystals are not radioopaque and are identified on polarized microscopy as negatively birefringent. Chronic gout can take years to develop and its findings include chronic synovitis, tophus formation, and erosions. Thus, the crystal induced tissue reaction in gout is different from other types of inflammatory arthritis where synovial inflammation is thought to be the predominant primary cause of tissue damage.
An experienced clinician or a specialist in gout can make the diagnosis on clinical grounds and laboratory findings and provide optimal management with little or no help from imaging, except in certain cases where the presentation mimics mass lesions or infection or when the deeper structures like the spine and sacroiliac joints are involved. However, a majority of patients with gout present to and are being cared for by nonspecialists, and the management remains suboptimal [5–7]. In such scenarios, imaging may have a helpful adjunct role in the diagnosis and management of gout, for the inexperienced provider. The awareness of recent advances in the imaging of gout, specifically in the field of high-frequency, high-resolution ultrasound (US) and dual energy computer tomography (DECT) will help clinicians use imaging where appropriate and for the sonographers and radiologists to be more confident in the diagnosis of gout. The aim of this paper is to review and familiarize the reader with the imaging (radiographs, US, computed tomography (CT), DECT, and magnetic resonance imaging (MRI)) and findings of gout.
Common imaging findings of gout are described in Table 1. Comparative utility of X rays, US, CT and MRI in the diagnosis of gout is discussed in Table 2. Advanced imaging is very sensitive in demonstrating aggregates of MSU crystals in soft tissue, joint, and bone. The extent and distribution of the crystal deposits have been greater than previously thought. The previous misconception is likely due to the fact that MSU crystals dissolve in formalin, and therefore, were not routinely identified in fixed pathological specimens. In addition, areas of crystal deposition were not routinely examined during autopsies.
The surface of joint cartilage and most tendons and ligaments are well shown by sonography. MSU crystals in tophaceous deposits around joints and deposits in tendons and soft tissues are well identified by DECT. CT can clearly demonstrate tophi growing into the adjacent bone, causing joint erosions with over hanging margins. MRI is the only clinical imaging modality which accurately shows bone marrow edema. Both ultrasound with Doppler imaging and MRI with contrast show increased vascularity associated with inflammation surrounding crystal deposits, sometimes even during intercritical periods.
Imaging is diagnostic in identifying tophi presenting as mass lesions or with symptoms of significant limitation of movement and pain, in superficial soft tissues (like patellar tendon, ankle tendons, and carpal tunnel) and deeper (like cruciate ligament in the knee and spine) structures. Tophi involving the flexor tendons at the carpal tunnel are well detected by ultrasound . These tophi resolve with proper serum uric acid lowering treatment , and the progressive resolution can be followed by imaging.
Radiographic findings of gout occur late in the disease and underestimate the degree of involvement; hence, their role in diagnosis and management is limited. Characteristic radiographic findings of gout include, first MTP involvement (Figure 1), juxta-articular erosions with sclerotic margins and overhanging edges, and preservation of joint spaces and periarticular bone density until late in the disease process. McQueen et al.  proposed a cellular mechanism to explain the characteristic erosion appearances of overhanging edge. Osteoclasts are activated at the bone tophus interface, whereas osteoblasts are inhibited resulting in marked localized bone loss . Gout deposits around joints can be juxta-articular, intra-articular, and subchondral (Figures 1 and 2) and usually do not demonstrate symmetric joint involvement. The tophus, the hallmark of chronic gout, is a soft tissue nodule representing the body’s granulomatous immune reaction to MSU crystals  (Figure 2). Dense calcification in the tophus is a late finding and may be associated with disturbance in calcium metabolism (Figure 3). Erosions are often located next to a tophus (Figure 3).
Sonography is able to depict tophaceous deposits in soft tissues, joints, cartilage, as well as erosions, synovitis, and increased vascularity, without the use of contrast agents. Recent studies published support a positive role for US in the early diagnosis of gout and in monitoring treatment response [12, 13]. US may depict urate deposition over the most superficial layer of hyaline cartilage as an irregular echogenic line producing the “double contour sign”  (Figure 4). This sign has been noted in patients with an acute gout flare up, with a history of prior gout attacks, and with asymptomatic hyperuricaemia. The sensitivity of this finding ranges from 25% to 95% in patients with gout [15–19]. However, these studies are small, with varied study designs. It has been suggested that this sign can be seen as an early ultrasound finding in gout, even before the development of erosive changes. Further studies are needed to document the sensitivity and specificity of this sign in the early diagnosis of gout and its prognostic significance in patients with asymptomatic hyperuricaemia.
The characteristic US appearance of a tophus includes an anechoic halo and hyperechoic heterogeneous center  (Figure 5). The peripheral anechoic halo likely represents the fibrovascular zone  noted in histology, with a more central hyperechoic synovial proliferation. Sometimes the tophus can be ill defined, traversing multiple fascial planes. Tophi that are sonolucent have been termed as “soft tophi” whilst long standing tophi that do not allow imaging of structures below them are termed as “hard tophi” .
Synovitis in gout demonstrates mixed echogenicity on ultrasound, being predominantly hyperechoic and often associated with increased vascularity (Figure 6). It tends to be more concentric, unlike the frond-like synovial hypertrophy noted in rheumatoid arthritis . In some cases, floating hyperechoic foci have been described, likely representing microtophi, resulting in “snow storm appearance”  (Figure 7). Ultrasound is excellent for identifying bursitis (Figure 8), intratendinous deposition (Figure 9), enthesitis, and subcutaneous nodules seen with gout (Figure 10).
A joint effusion is an early but nonspecific finding in gout patients (Figure 11). Ultrasound is also the primary imaging modality used for needle guidance during diagnostic and therapeutic interventions, including aspirating fluid for crystals. Ultrasound may assist evaluation in acute gout, in not only identifying the extra-articular structure involved, but also allowing needle guidance for fluid aspiration.
One pitfall of ultrasound imaging is its inability to image intraosseous gout. Caution must be used when diagnosing erosions with US. While it is true that US is more sensitive than radiographs for diagnosing erosions , US also can underestimate the extent and number of erosions, when compared to MRI . The specificity of an ultrasound diagnosis of erosions is increased when there is adjacent synovitis or tophi (Figure 12) .
Dual energy computed Tomography (DECT) has an established role in the assessment of coronary artery plaques and uric acid calculi . Its role in the diagnosis of gout is promising and evolving. Dual energy X-ray tubes at 80 kv and 140 kv are placed at 90 degrees to each other and to their two detectors. Images are acquired simultaneously. Based on the spectral dual energy properties, aggregates of urate crystals can be uniquely color coded, allowing for depiction and distinguishing alternative diagnosis, including other crystal deposition diseases, such as hydroxyapatite (Figure 13). This technique has a high accuracy in identifying cases of tophaceous gout and is very sensitive in detecting the volume of urate crystals relative to clinical examination . Further studies are required to assess DECT’s sensitivity and specificity in identifying very early nontophaceous gout without crystal aggregates (crystals less than 3 mm in size, microtophi, and crystals deposits on cartilage, etc.). DECT may be useful in evaluating patients with high clinical suspicion of tophaceous gout, in whom conventional diagnostic tests have been inconclusive. It may also help assess the presence of gout in atypical locations such as the spine.
Conventional CT is extremely sensitive in identifying characteristic gout erosions and tophus (Figure 14). Cost and radiation limit the routine use of CT. A tophaceous soft tissue nodule demonstrates a density of 170 Hounsfield units . A tophus can be intra- (Figure 15) or extra-articular, as well as located in tendons and subcutaneous tissues, showing preponderance to the pressure points. Tophi are known to diminish in size in response to treatment, which can be documented by serial cross-sectional imaging. Even though CT and MRI are more accurate, US is probably more practical for follow-up studies because it is easily available, relatively of low cost, and has no ionizing radiation.
MRI is helpful in the localization of gout deposit and can show gout in the deeper tissues like the spine and in locations not amenable to clinical examination, such as interosseous deposits in the midfoot (Figure 16). MRI is accurate in diagnosing the extent of gout involvement of the bursae and tendons, as well as any associated tendon tears (Figures 17, 18, 19, and 20). Tendon involvement by gout can mimic a mass lesion. A tophus histologically consists of central acellular crystalline core surrounded by “corona zone” and a peripheral “fibrovascular zone” . Tophi on MRI are low signal on T1-weighted MRI and mostly intermediate signal on T2-weighted MRI (Figure 21). Some can be high signal on T2-weighted MRI and can show significant enhancement in postcontrast images. This enhancement would be proportional to the vascularity predominantly in the outer “fibrovascular zone” seen on histology . Low signal foci on T2-weighted images most likely represent calcifications.
7. Imaging to Differentiate between Gout, Other Crystalline Arthropathy, and Infection
Clinically, the presentation of gout can mimic an infection. Superimposed infection should always be considered. The characteristic appearance and location of the osseous erosion with gout and the absence of an adjacent soft tissue ulcer are helpful findings that suggest gout. However, joint aspiration with examination of fluid under plane polarized microscopy and gram stain and cultures are advisable.
MSU crystals deposit on the surface of the articular cartilage as an echogenic curvilinear band paralleling the cortex, giving the appearance of a “double contour sign” on ultrasound (Figure 4). This is a distinctly different pattern as compared to calcium pyrophosphate crystal disease which usually results in crystal deposition within the cartilage rather than the surface . US is the most sensitive modality to pick up these differences.
8. Imaging in the Monitoring of Response to Treatment
With the advent of new and very effective treatment options for lowering urate levels in gout , there is a growing research interest in imaging to monitor treatment response. Such imaging changes include diminishing tophus size, disappearance of the “double contour sign,” and resolution of synovial hypertrophy, joint effusion, and bone marrow edema. Advanced 3D rendering of the tophus is now possible with both CT and MRI with CT considered more accurate and reproducible. DECT will identify the urate crystals, based on chemical composition, and will be more definitive and reliable in the followup of resolving tophus. MRI will retain its edge in following resolving synovial proliferation and bone marrow edema; however, ultrasound is an excellent and affordable alternative assessment method for all of the above imaging findings except marrow edema and provides fine details with excellent spatial resolution. While MRI is equally helpful in monitoring disease progression, for both clinical and research purposes, it is less readily available and more expensive. Therefore, ultrasound promises to be the modality of choice to monitor treatment response.
The role of imaging in the management of long standing gout is usually limited, except when looking for gout deposits in the deeper tissues, where sampling can be challenging. Sonography can be used for needle guidance to obtain tissue samples for diagnosis. Recent advances in the imaging of gout show promise and hopefully will lead to more accurate assessment of the activity of gout and assist in the diagnosis of atypical presentations of acute and tophaceous gout, including its response to therapy. The significance of asymptomatic hyperuricaemia with positive early imaging findings is still to be determined. Since ultrasound is a readily available, nonionizing modality which can depict many features of gout, as well as assist with needle guidance, it may be a preferred modality for imaging gout.
- Y. Zhu, B. J. Pandya, and H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008,” Arthritis & Rheumatism, vol. 63, no. 10, pp. 3136–3141, 2011.
- P. Richette and T. Bardin, “Gout,” The Lancet, vol. 375, no. 9711, pp. 318–328, 2010.
- C. A. Agudelo and H. R. Schumacher, “The synovitis of acute gouty arthritis. A light and electron microscopic study,” Human Pathology, vol. 4, no. 2, pp. 265–279, 1973.
- W. Zhang, M. Doherty, T. Bardin et al., “EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT),” Annals of the Rheumatic Diseases, vol. 65, no. 10, pp. 1312–1324, 2006.
- M. P. Keith and W. R. Gilliland, “Updates in the management of Gout,” American Journal of Medicine, vol. 120, no. 3, pp. 221–224, 2007.
- T. R. Mikuls, J. T. Farrar, W. B. Bilker, S. Fernandes, and K. G. Saag, “Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD),” Rheumatology, vol. 44, no. 8, pp. 1038–1042, 2005.
- J. A. Singh, J. S. Hodges, J. P. Toscano, and S. M. Asch, “Quality of care for gout in the US needs improvement,” Arthritis Care and Research, vol. 57, no. 5, pp. 822–829, 2007.
- A. Therimadasamy, Y. P. Peng, T. C. Putti, and E. P. Wilder-Smith, “Carpal tunnel syndrome caused by gouty tophus of the flexor tendons of the fingers: sonographic features,” Journal of Clinical Ultrasound, vol. 39, no. 8, pp. 463–465, 2011.
- F. Perez-Ruiz, I. Martin, and B. Canteli, “Ultrasonographic measurement of tophi as an outcome measure for chronic gout,” Journal of Rheumatology, vol. 34, no. 9, pp. 1888–1893, 2007.
- F. M. McQueen, A. Chhana, and N. Dalbeth, “Mechanisms of joint damage in gout: evidence from cellular and imaging studies,” Nature Reviews Rheumatology, vol. 8, pp. 173–181, 2012.
- N. Dalbeth, B. Pool, G. D. Gamble et al., “Cellular characterization of the gouty tophus: a quantitative analysis,” Arthritis and Rheumatism, vol. 62, no. 5, pp. 1549–1556, 2010.
- F. M. McQueen, A. Doyle, and N. Dalbeth, “Imaging in gout—what can we learn from MRI, CT, DECT and US?” Arthritis Research & Therapy, vol. 13, p. 246, 2011.
- S. Ottaviani, T. Bardin, and P. Richette, “Usefulness of ultrasonography for gout,” Joint Bone Spine, vol. 79, no. 5, pp. 441–445, 2012.
- R. G. Thiele and N. Schlesinger, “Diagnosis of gout by ultrasound,” Rheumatology, vol. 46, no. 7, pp. 1116–1121, 2007.
- E. Filippucci, M. Gutierrez Riveros, D. Georgescu, F. Salaffi, and W. Grassi, “Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study,” Osteoarthritis and Cartilage, vol. 17, no. 2, pp. 178–181, 2009.
- R. G. Howard, M. H. Pillinger, S. Gyftopoulos, R. G. Thiele, C. J. Swearingen, and J. Samuels, “Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers,” Arthritis Care & Research, vol. 63, no. 10, pp. 1456–1462, 2011.
- C. Pineda, L. M. Amezcua-Guerra, C. Solano et al., “Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study,” Arthritis Research and Therapy, vol. 13, no. 1, p. R4, 2011.
- R. G. Thiele, “Role of ultrasound and other advanced imaging in the diagnosis and management of gout,” Current Rheumatology Reports, vol. 13, no. 2, pp. 146–153, 2011.
- S. A. Wright, E. Filippucci, C. McVeigh et al., “High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study,” Annals of the Rheumatic Diseases, vol. 66, no. 7, pp. 859–864, 2007.
- E. de Avila Fernandes, E. S. Kubota, G. B. Sandim, S. A. V. Mitraud, A. J. L. Ferrari, and A. R. C. Fernandes, “Ultrasound features of tophi in chronic tophaceous gout,” Skeletal Radiology, vol. 40, no. 3, pp. 309–315, 2011.
- W. Grassi, G. Meenagh, E. Pascual, and E. Filippucci, “‘Crystal Clear’-sonographic assessment of Gout and calcium pyrophosphate deposition disease,” Seminars in Arthritis and Rheumatism, vol. 36, no. 3, pp. 197–202, 2006.
- T. Rettenbacher, S. Ennemoser, H. Weirich et al., “Diagnostic imaging of gout: comparison of high-resolution US versus conventional X-ray,” European Radiology, vol. 18, no. 3, pp. 621–630, 2008.
- J. D. Carter, R. P. Kedar, S. R. Anderson et al., “An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs,” Rheumatology, vol. 48, no. 11, pp. 1442–1446, 2009.
- N. Dalbeth, B. Clark, K. Gregory et al., “Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography,” Annals of the Rheumatic Diseases, vol. 68, no. 8, pp. 1290–1295, 2009.
- M. Karcaaltincaba and A. Aktas, “Dual-energy CT revisited with multidetector CT: review of principles and clinical applications,” Diagnostic and Interventional Radiology, vol. 17, no. 3, pp. 181–194, 2011.
- H. K. Choi, A. M. Al-Arfaj, A. Eftekhari et al., “Dual energy computed tomography in tophaceous gout,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1609–1612, 2009.
- J. C. Gerster, M. Landry, L. Dufresne, and J. Y. Meuwly, “Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography,” Annals of the Rheumatic Diseases, vol. 61, no. 1, pp. 52–54, 2002.
- D. G. Palmer, N. Hogg, I. Denholm, C. A. Allen, J. Highton, and P. A. Hessian, “Comparison of phenotype expression by mononuclear phagocytes within subcutaneous gouty tophi and rheumatoid nodules,” Rheumatology International, vol. 7, no. 5, pp. 187–193, 1987.
- A. So and N. Busso, “Update on gout 2012,” Joint Bone Spine, vol. 79, no. 6, pp. 539–543, 2012.
Copyright © 2013 Gandikota Girish et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.